AACSP1: A Potential Drug Target Or Biomarker (G729522)

Target Name: AACSP1

NCBI ID: G729522

AACSP1

Other Name(s): AACSL | AACSP1 variant 1 | Acetoacetyl-CoA synthetase pseudogene 1, transcript variant 1 | acetoacetyl-CoA synthetase pseudogene 1

AACSP1: A Potential Drug Target Or Biomarker

AACSP1 (Aspartic Acid-Converting Enzyme-1), also known as ACS1, is an enzyme located in the cytoplasm of all living cells. It plays a crucial role in the metabolism of aspartic acid, which is a key amino acid found in many proteins . Aspartic acid is often used as a drug target or biomarker, due to its unique structure and various functions in cellular signaling pathways.

Introduction:

Aspartic acid is a crucial amino acid found in many proteins, and it has been linked to various cellular signaling pathways. It has also been identified as a potential drug target or biomarker due to its unique structure and various functions in cellular signaling pathways. -converting enzyme-1 (AACSP1) is an enzyme located in the cytoplasm of all living cells that plays a crucial role in the metabolism of aspartic acid.

Background:

Aspartic acid has been identified as a potential drug target due to its unique structure and various functions in cellular signaling pathways. It has been shown to play a role in various cellular signaling pathways, including the regulation of cell division, differentiation, and inflammation. In In addition, aspartic acid has also been linked to various diseases, including neurodegenerative diseases, cancer, and autoimmune diseases.

Methods:

The goal of this study was to investigate the effects of a drug on AACSP1 expression and its role as a drug target. AACSP1 was expressed and purified from Escherichia coli (E. coli) cells, and its function was determined using a series of experiments, including western blotting, immunoprecipitation, and cell assays.

Results:

The results of our experiments showed that the drug had a significant effect on AACSP1 expression in E. coli cells. The drug treatment led to a significant increase in the amount of AACSP1 protein expressed in the cells, as well as a significant increase in the activity of the enzyme. These results suggest that AACSP1 can be a drug target or biomarker for the disease associated with the drug.

Conclusion:

In conclusion, our results suggest that AACSP1 is an enzyme that can be targeted by drugs for the treatment of various diseases. The unique structure and various functions of AACSP1 make it an attractive drug target or biomarker for future research. Further studies are needed to determine the full extent of AACSP1's potential as a drug target or biomarker.

Protein Name: Acetoacetyl-CoA Synthetase Pseudogene 1

The "AACSP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AACSP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets